PARK7 and breast carcinoma: Additionally, tissue-specific analyses revealed consistent expression patterns of PARK7 across thyroid, breast, muscle, and subcutaneous adipose tissues compared to blood, suggesting its potential to perform similar biological functions across different tissues and supporting its potential value as a breast cancer biomarker.